Pathology service run jointly with Serco is “in turmoil,” claims reportBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e6665 (Published 02 October 2012) Cite this as: BMJ 2012;345:e6665
- Nigel Hawkes
A joint venture in pathology services between two London trusts and the private sector company Serco has yet to turn a profit, and its management has admitted that it had underestimated the task and was now trying to recover from a poor start.
GSTS Pathology was set up as a partnership between Serco and Guy’s and St Thomas’s NHS Foundation Trust in 2009 after a review of pathology services carried out in 2006 by the Labour peer Patrick Carter had recommended that savings could be made if pathology services were delivered by specialised service providers.1 King’s College Hospital joined in 2010. In 2011 the joint venture lost £5.9m (€7.4m; $9.5m) on a turnover of £85m.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial